XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues and other income:      
Operating revenues $ 2,930,126 $ 3,005,981 $ 2,653,766
Investment income (loss) 38,713 43,820 14,992
Total revenues and other income 2,968,839 3,049,801 2,668,758
Costs and other deductions:      
Direct costs 1,742,411 1,790,380 1,666,004
General and administrative expenses 249,317 244,147 228,431
Research and engineering 57,063 56,297 49,939
Depreciation and amortization 633,408 645,294 665,072
Interest expense 210,864 185,285 177,895
Other, net 106,816 (726) 127,099
Total costs and other deductions 2,999,879 2,920,677 2,914,440
Income (loss) before income taxes (31,040) 129,124 (245,682)
Income tax expense (benefit):      
Current 35,263 63,339 54,199
Deferred 21,684 15,881 7,337
Total income tax expense (benefit) 56,947 79,220 61,536
Net income (loss) (87,987) 49,904 (307,218)
Less: net (income) loss attributable to noncontrolling interest (88,097) (61,688) (43,043)
Net income (loss) attributable to Nabors $ (176,084) $ (11,784) $ (350,261)
Earnings (losses) per share:      
Basic (in dollars per share) $ (22.37) $ (5.49) $ (40.52)
Diluted (in dollars per share) $ (22.37) $ (5.49) $ (40.52)
Weighted-average number of common shares outstanding:      
Basic (in shares) 9,202 9,159 8,898
Diluted (in shares) 9,202 9,159 8,898